Efficiency of endoscopic treatment with intra gastric balloon in severe to morbid obesity
##plugins.themes.academic_pro.article.main##
Abstract
Background: Obesity raises such a healthcare matter throughout the world. Its management is not only complex but also most often multidisciplinary. The medico-dietary treatment is of inconstant efficiency and the surgical treatment, though more efficient, presents a considerable morbidity-death rate. The endoscopic treatment through intra-gastric balloon avails a seducing alternative namely accounting for surgery preparation. Aim: To assess the efficiency of the endoscopic treatment through gastric balloon, both in the short and long term, and this is accounting for weight loss as well as tolerance.
Methods: We have carried out a retrospective study including the patients suffering from severe to morbid obesity and who had a gastric balloon implemented in our Endoscopy Unit between November 2005 and December 2007.
Results: Twenty one patients were included. The average age was 32,19 ± 12,65 years with extremes of 16 and 52 years. Fifteen patients suffered from morbid obesity. The patients’ average weight was 134, 52 ± 26,46 kg (extremes 88 and 194 kg). Some co-morbidity was found out with 15 patients. Te balloon implementation (Héliosphère®) was carried out with no incidents in all patients. Six months after the balloon implementation, the average weight loss was17,5% and the average loss of overweigh was 37%. In biological level, we noted a normalisation of fasting glycaemia in 28,6 % of cases, of the cholesterolemia in 100 %, of the triglyceridemia in 33,33%, of the uraemia in 42,8% and hepatic tests in 50 % of the cases. The metabolic syndrome disappeared in 28,57 % of cases. The assessment after a 5-year-period was marked by the need to surgical treatment in 4 patients and this is due to the loss of efficiency of endoscopic treatment. A bad tolerance of gastric balloon was observed in 34 % of the cases, dominated by sicknesses. Only one patient presented incoercible sicknesses with ionic troubles as well as deshydrating requiring the precocious extraction of the balloon after 48 hours of its implementation.
Conclusion: The endoscopic treatment through intra gastric balloon is well tolerated but efficiently limited in time. It might be recommended in preparation for a surgical treatment or in case of contre- indication or surgery refusal.
Methods: We have carried out a retrospective study including the patients suffering from severe to morbid obesity and who had a gastric balloon implemented in our Endoscopy Unit between November 2005 and December 2007.
Results: Twenty one patients were included. The average age was 32,19 ± 12,65 years with extremes of 16 and 52 years. Fifteen patients suffered from morbid obesity. The patients’ average weight was 134, 52 ± 26,46 kg (extremes 88 and 194 kg). Some co-morbidity was found out with 15 patients. Te balloon implementation (Héliosphère®) was carried out with no incidents in all patients. Six months after the balloon implementation, the average weight loss was17,5% and the average loss of overweigh was 37%. In biological level, we noted a normalisation of fasting glycaemia in 28,6 % of cases, of the cholesterolemia in 100 %, of the triglyceridemia in 33,33%, of the uraemia in 42,8% and hepatic tests in 50 % of the cases. The metabolic syndrome disappeared in 28,57 % of cases. The assessment after a 5-year-period was marked by the need to surgical treatment in 4 patients and this is due to the loss of efficiency of endoscopic treatment. A bad tolerance of gastric balloon was observed in 34 % of the cases, dominated by sicknesses. Only one patient presented incoercible sicknesses with ionic troubles as well as deshydrating requiring the precocious extraction of the balloon after 48 hours of its implementation.
Conclusion: The endoscopic treatment through intra gastric balloon is well tolerated but efficiently limited in time. It might be recommended in preparation for a surgical treatment or in case of contre- indication or surgery refusal.
Keywords:
Obesity - intra-gastric balloon- endoscopy##plugins.themes.academic_pro.article.details##
References
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: 1; 1998
- Stunkard AJ, Harris JR, Pedersen NL, Mc Clearn GE. The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483-7.
- Merrouche M, Coffin B. Obésité: prise en charge, indications et méthodes du traitement endoscopique et chirurgical. EMC-HépatoGastroentérologie 2005; 2: 189-200.
- Catheline JM, Roussel J, Bénichou J. Traitement chirurgical de l'obésité. Réanimation 2006; 15: 433-8
- The World Health Organization 2005 data. Available at: http://www.who.int/ncd_surveillance
- INNTA. Evaluation de l'état nutritionnel de la population tunisienne. Enquête nationale 1996/97. Minsitère de la santé publique, Tunis 2000: 312p
- Kamoun M, Hajem S, Imen S, Achour N, Slimane H. Prevalence of obesity and overweight in Tunisia on 2001. Tunis Med 2008; 86: 649-52.
- Arnaud Basdevant. L'obésité: origines et conséquences d'une épidémie. C. R. Biologies 2006; 329: 562-9
- Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982; 1: 198-9.
- Tsesmeli N, Coumaros D. Review of endoscopic devices for weight reduction: old and new balloons and implantable prostheses. Endoscopy 2009; 41: 1082-9.
- Forestieri P, De Palma GD, Formato A et al. Heliosphere® Bag in the Treatment of Severe Obesity: Preliminary Experience. Obes Surg 2006; 16: 635-7
- Mion F, Gincul R, Roman S, et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obes Surg 2007; 17: 764-9.
- Trande P, Mussetto A, Mirante VG et al. Efficacy, Tolerance and Safety of New Intragastric Air-Filled Balloon (Heliosphere BAG) for Obesity: the Experience of 17 Cases. Obes Surg 2008; 22: 954-7
- Ibrahim M, Blero D, Deviere J et al. Endoscopic Options for the Treatment of Obesity. Gastroenterology 2010; 138: 2228-32
- Crea N, Pata G, Della Casa D et al. Improvement of Metabolic Syndrome Following Intragastric Balloon: 1 Year Follow-up Analysis. Obes Surg 2009; 19:1084-8
- Coskun H, Bostanci O, Dilege E et al. BioEnterics Intragastric Balloon: Clinical Outcomes of the First 100 Patients—A Turkish Experience. Obes Surg 2008; 18: 1154-6.
- Dumonceau JM. Evidence-based Review of the Bioenterics Intragastric Balloon for Weight Loss. Obes Surg 2008; 18: 1611-7
- year after the intragastric balloon has been removed? Obes Surg 2005; 15: 864-70
- Mui WL, Ng EK, Tsung BY, Lam CH, Yung MY. Impact on ObesityRelated Illnesses and Quality of Life Following Intragastric Balloon. Obes Surg 2010; 20: 1128-32.
- Sallet JA, Marchesini JB, Paiva DS. Brazilian multicenter study of the intragastric balloon. Obes Surg 2004; 14: 991-8
- Alfalah H, Philippe B, Ghazal F et al. Intragastric Balloon for Preoperative Weight Reduction in Candidates for Laparoscopic Gastric Bypass with Massive Obesity. Obes Surg 2006; 16: 147-50
- Roman S, Napoléon B, Mion F al. Intragastric Balloon for “Non-Morbid” Obesity: A Retrospective evaluation of Tolerance and Efficacy. Obes Surg 2004; 14: 539-44.
- Ohta M, Kitano S, Kai S et al. Initial Japanese Experience with Intragastric Balloon Placement. Obes Surg 2009; 19: 791-95.
- Ricci G, Bersani G, Rossi A, Pigò F, De Fabritiis G, Alvisi V. Bariatric Therapy with Intragastric Balloon Improves Liver Dysfunction and Insulin Resistance in Obese Patients. Obes Surg 2008; 18: 1438-42
- Imaz I, MartÃnez-Cervell C, GarcÃa-Alvarez EE, Sendra-Gutiérrez JM, González-EnrÃquez J. Safety and Effectiveness of the Intragastric Balloon for Obesity: A Meta-Analysis. Obes Surg 2008; 18: 841-6.
- Anil DR, Ganesh R. The intragastric balloon as treatment for obesity: long-term followup in asian patients. Surg Obes 2008; 4: 318-357.
- Dastis NS, François E, Deviere J et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy 2009; 41: 575-80
- Genco A, Bruni T, Doldi SB et al. BioEnterics Intragastric Balloon: The Italian Experience with 2515 Patients. Obes Surg 2005; 15: 1161-4.